Karuna Therapeutics, Inc.
Karuna Therapeutics, Inc.（KRTX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · KRTX · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
53
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Karuna Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
KRTX 季度内部人买卖趋势
KRTX 内幕交易卖出 · KRTX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
KRTX 高管卖出股份 · KRTX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 18, 2024 | Wheadon David E. Director | Other | 990 | $327K | Form 4 |
| Mar 18, 2024 | Torres Denice Director | Other | 990 | $327K | Form 4 |
| Mar 18, 2024 | Pande Atul Director | Other | 990 | $327K | Form 4 |
| Mar 18, 2024 | OLSON LAURIE J Director | Other | 990 | $327K | Form 4 |
| Mar 18, 2024 | JONAS JEFFREY M Director | Other | 990 | $327K | Form 4 |
| Mar 18, 2024 | HEALY JAMES Director | Other | 32,500 | $10.72M⚡ | Form 4 |
| Mar 18, 2024 | HEALY JAMES Director | Other | 8,025 | $2.65M⚡ | Form 4 |
| Mar 18, 2024 | Miller Andrew Craig President of R&D | Other | 13,977 | $4.61M⚡ | Form 4 |
| Mar 18, 2024 | PAUL STEVEN M Director | Other | 2,046 | $675K | Form 4 |
| Mar 18, 2024 | PAUL STEVEN M Director | Other | 35,877 | $11.84M⚡ | Form 4 |
| Mar 18, 2024 | Miller Andrew Craig President of R&D | Other | 9,412 | $3.11M⚡ | Form 4 |
| Mar 18, 2024 | COUGHLIN CHRISTOPHER J Director | Other | 990 | $327K | Form 4 |
| Mar 18, 2024 | Brown Jason Parker CFO | Other | 14,009 | $4.62M⚡ | Form 4 |
| Mar 18, 2024 | Brown Jason Parker CFO | Other | 7,158 | $2.36M⚡ | Form 4 |
| Mar 18, 2024 | Meury William President and CEO · Director | Other | 10,342 | $3.41M⚡ | Form 4 |
| Mar 18, 2024 | Meury William President and CEO · Director | Other | 19,037 | $6.28M⚡ | Form 4 |
| Mar 18, 2024 | Kane William P Jr Chief Commercial Officer | Other | 5,000 | $1.65M⚡ | Form 4 |
| Mar 18, 2024 | Kane William P Jr Chief Commercial Officer | Other | 8,828 | $2.91M⚡ | Form 4 |
| Mar 18, 2024 | Brannan Stephen K. Chief Medical Officer | Other | 36,117 | $11.92M⚡ | Form 4 |
| Mar 18, 2024 | Brannan Stephen K. Chief Medical Officer | Other | 6,487 | $2.14M⚡ | Form 4 |
| Mar 8, 2024 | Brannan Stephen K. Chief Medical Officer | Option | 1,791 | $201K | Form 4 |
| Mar 8, 2024 | Brannan Stephen K. Chief Medical Officer | Option | 3,209 | $422K | Form 4 |
| Mar 8, 2024 | Brannan Stephen K. Chief Medical Officer | Sale | 4,900 | $1.56M⚡ | Form 4 |
| Mar 8, 2024 | Brannan Stephen K. Chief Medical Officer | Sale | 100 | $32K | Form 4 |
| Mar 8, 2024 | Brannan Stephen K. Chief Medical Officer | Option | 2,500 | $14K | Form 4 |
Meury William
President and CEO · Director
日期
Mar 18
股数
10,342
均价
$330.00
总金额
$3.41M ⚡
Meury William
President and CEO · Director
日期
Mar 18
股数
19,037
均价
$330.00
总金额
$6.28M ⚡
Kane William P Jr
Chief Commercial Officer
日期
Mar 18
股数
5,000
均价
$330.00
总金额
$1.65M ⚡
Kane William P Jr
Chief Commercial Officer
日期
Mar 18
股数
8,828
均价
$330.00
总金额
$2.91M ⚡
Brannan Stephen K.
Chief Medical Officer
日期
Mar 18
股数
36,117
均价
$330.00
总金额
$11.92M ⚡
Brannan Stephen K.
Chief Medical Officer
日期
Mar 18
股数
6,487
均价
$330.00
总金额
$2.14M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 KRTX 内幕交易
KRTX 内幕交易
Karuna Therapeutics, Inc.（KRTX）内幕交易数据来源于公司内部人（包括KRTX）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。KRTX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Karuna Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
KRTX 内幕交易 · 5个问题Karuna Therapeutics, Inc.（KRTX）的内部人包括高管和董事，如KRTX等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026